Clinicopathological significance of vascular endothelial growth factor-C and cyclooxygenase-2 in esophageal squamous cell carcinoma

Journal of Gastroenterology and Hepatology (Australia)

Volumn 19, Issue 6, 2004, Pages 648-654

  Byeon, Jeong Sik ^a   Jung, Hwoon Yong ^a   Lee, Yun Jung ^a   Lee, Don ^a   Lee, Gin Hyug ^a   Myung, Seung Jae ^a   Yang, Suk Kyun ^a   Hong, Weon Seon ^a   Kim, Jin Ho ^a,b   Min, Young Il ^a   Kim, Jung Sun ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Asan Medical Center   (South Korea)

Author keywords

Cyclooxygenase 2; Endoscopic mucosal resection; Esophageal squamous cell carcinoma; Vascular endothelial growth factor C

Indexed keywords

CYCLOOXYGENASE 2; VASCULOTROPIN C;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CLINICAL ARTICLE; CONTROLLED STUDY; EARLY CANCER; ENDOSCOPIC SURGERY; ESOPHAGUS CARCINOMA; ESOPHAGUS MUCOSA; EVALUATION; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; MEDICAL RECORD; PATIENT INFORMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SQUAMOUS CELL CARCINOMA; TISSUE SECTION; TUMOR GROWTH;

EID: 3042742747     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2004.03348.x     Document Type: Article

References (34)

1. Ichikura T, Tomimatsu S, Ohkura E, Mochizuki H. Prognostic significance of the expression of vascular endothelial growth factor (VEGF) and VEGF-C in gastric carcinoma. J. Surg. Oncol. 2001; 78: 132-7.
2. O-charoenrat P, Rhys-Evans P, Eccles SA. Expression of vascular endothelial growth factor family members in head and neck squamous cell carcinoma correlates with lymph node metastasis. Cancer 2001; 92: 556-68.
3. Yuan A, Yu CJ, Chen WJ et al. Correlation of total VEGF mRNA and protein expression with histologic type, tumor angiogenesis, patient survival and timing of relapse in non-small-cell lung cancer. Int. J. Cancer 2000; 89: 475-83.
4. Seo Y, Baba H, Fukuda T, Takashima M, Sugimachi K. High expression of vascular endothelial growth factor is associated with liver metastasis and a poor prognosis for patients with ductal pancreatic adenocarcinoma. Cancer 2000; 88: 2239-45.
5. Okada F, Rak JW, Croix BS et al. Impact of oncogenes in tumor angiogenesis: mutant K-ras up-regulation of vascular endothelial growth factor/vascular permeability factor is necessary, but not sufficient for tumorigenicity of human colorectal carcinoma cells. Proc. Natl Acad. Sci. USA 1998; 95: 3609-14.
6. Petit AM, Rak J, Hung MC et al. Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors. Am. J. Pathol. 1997; 151: 1523-30.
7. Gleadle JM, Ratcliffe PJ. Hypoxia and the regulation of gene expression. Mol. Med. Today 1998; 4: 122-9.
8. Cianchi F, Cortesini C, Bechi P et al. Up-regulation of cyclooxygenase 2 gene expression correlates with tumor angiogenesis in human colorectal cancer. Gastroenterology 2001; 121: 1339-47.
9. Saaristo A, Karpanen T, Alitalo K. Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis. Oncogene 2000; 19: 6122-9.
10. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 1999; 13: 9-22.
11. Valtola R, Salven P, Heikkila P et al. VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer. Am. J. Pathol. 1999; 154: 1381-90.
12. Saaristo A, Partanen TA, Arola J et al. Vascular endothelial growth factor-C and its receptor VEGFR-3 in the nasal mucosa and in nasopharyngeal tumors. Am. J. Pathol. 2000; 157: 7-14.
13. Kitadai Y, Amioka T, Haruma K et al. Clinicopathological significance of vascular endothelial growth factor (VEGF)-C in human esophageal squamous cell carcinomas. Int. J. Cancer 2001; 93: 662-6.
14. Yonemura Y, Endo Y, Fujita H et al. Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer. Clin. Cancer Res. 1999; 5: 1823-9.
15. Ginsberg GG, Fleischer DE. Esophageal tumors. In: Feldman M, Friedman LS, Sleisenger MH, eds. Sleisenger and Fordtran's Gastrointestinal and Liver Disease: Pathophysiology/Diagnosis/Management, 7th edn. Philadelphia: Saunders, 2002; 647-71.
16. Noguchi T, Takeno S, Shibata T, Uchida Y, Yokoyama S, Muller W. VEGF-C expression correlates with histological differentiation and metastasis in squamous cell carcinoma of the esophagus. Oncol. Rep. 2002; 9: 995-9.
17. American Joint Committee on Cancer. AJCC Cancer Staging Manual, 5th edn. Philadelphia: Lippincott-Raven, 1997.
18. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N. Engl. J. Med. 1991; 324: 1-8.
19. Araki K, Ohno S, Egashira A, Saeki H, Kawaguchi H, Sugimachi K. Pathologic features of superficial esophageal squamous cell carcinoma with lymph node and distal metastasis. Cancer 2002; 94: 570-5.
20. Natsugoe S, Baba M, Yoshinaka H et al. Mucosal squamous cell carcinoma of the esophagus: a clinicopathologic study of 30 cases. Oncology 1998; 55: 235-41.
21. Furudoi A, Tanaka S, Haruma K et al. Clinical significance of vascular endothelial growth factor C expression and angiogenesis at the deepest invasive site of advanced colorectal carcinoma. Oncology 2002; 62: 157-66.
22. Kabashima A, Maehara Y, Kakeji Y, Sugimachi K. Overexpression of vascular endothelial growth factor C is related to lymphogenous metastasis in early gastric carcinoma. Oncology 2001; 60: 146-50.
23. Tsurusaki T, Kanda S, Sakai H et al. Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis. Br. J. Cancer 1999; 80: 309-13.
24. Shimizu Y, Tsukagoshi H, Fujita M, Hosokawa M, Kato M, Asaka M. Long-term outcome after endoscopic mucosal resection in patients with esophageal squamous cell carcinoma invading the muscularis mucosae or deeper. Gastrointest. Endosc. 2002; 56: 387-90.
25. Takeo Y, Yoshida T, Shigemitu T, Yanai H, Hayashi N, Okita K. Endoscopic mucosal resection for early esophageal cancer and esophageal dysplasia. Hepatogastroenterology 2001; 48: 453-7.
26. Fukuda M, Hirata K, Natori H. Endoscopic ultrasonography of the esophagus. World J. Surg. 2000; 24: 216-26.
27. Natsugoe S, Nakashima S, Matsumoto M et al. Biologic and imaging diagnosis of lymph node metastasis in esophageal carcinoma. J. Surg. Oncol. 2002; 81: 25-32.
28. Hasan J, Byers R, Jayson GC. Intra-tumoural microvessel density in human solid tumours. Br. J. Cancer 2002; 86: 1566-77.
29. Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M, DuBois RN. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 1998; 93: 705-16.
30. Oshima M, Murai N, Kargman S et al. Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor. Cancer Res. 2001; 61: 1733-40.
31. Wang L, Zhang W, Wang W. A study on cyclooxygenase-2 protein expression in esophageal carcinoma and premalignant lesions. Chin. J. Oncol. 2001; 23: 14-16.
32. Kawabe A, Shimada Y, Uchida S et al. Expression of cyclooxygenase-2 is associated with carcinogenesis of the lower part of thoracic esophageal squamous cell carcinoma and p53 expression. Oncology 2002; 62: 46-54.
33. Ratnasinghe D, Tangrea J, Roth MJ et al. Expression of cyclooxygenase-2 in human squamous cell carcinoma of the esophagus; an immunohistochemical survey. Anticancer Res. 1999; 19: 171-4.
34. Zhang W, Wang L, Chang A, Jin Y, Rao J. Immunohistochemical analysis of cyclooxygenase-2 expression in premalignant and malignant esophageal glandular and squamous lesions in Cixian, China. Cancer Detect. Prev. 2003; 27: 243-9.